Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Break Up Speculation Lifts Old Mutual

Mon, 07th Mar 2016 10:40

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.
----------
FTSE 100 - WINNERS
----------
Old Mutual, up 6.6%. The Anglo-South African financial services group said "all options" are being considered for its strategic review but no decision has yet been made, in response to a report from Sky News that the company is planning a break up of its operations. Sky News reported Old Mutual is planning to split into four standalone units. This would comprise its stake in South African lender Nedbank, its UK-focused wealth management unit, its South Africa-based emerging markets operation, and its institutional asset management business. Shore Capital's Eamonn Flanagan believes that a disposal or demerger of Old Mutual Wealth is a possibility. "The interaction with the South African life and banking operations is pretty limited and, indeed, probably introduces the conglomerate discount that the stock has traded on for quite a while," Flanagan said.

GlaxoSmithKline, up 0.4%. The pharmaceutical giant said results from its long-term safety study of Advair Diskus for the treatment of adults and adolescents with asthma were published in the New England Journal of Medicine. The study, which reported results in October, compared Advair Diskus to a monotherapy of fluticasone propionate. The results were simultaneously presented at the American Academy of Asthma, Allergy and Immunology Congress in Los Angeles, California, where the company also released new data from a long-term efficacy and safety study of Nucala in severe asthma with an eosinophilic phenotype.
----------
FTSE 100 - LOSERS
----------
Anglo American, down 4.3%. UBS downgraded the miner to Sell from Neutral

Randgold Resources, down 4.6%. The gold miner was cut to Equal-Weight from Overweight by Morgan Stanley.

InterContinental Hotels Group, down 2.2%. CitiGroup downgraded IHG, which operates Holiday Inn and Crowne Plaza hotels, to Sell from Neutral.
----------
FTSE 250 - LOSERS
----------
Clarkson, down 2.9%. The shipping services group said it will increase its dividend once again after it achieved a 26% rise in profit and a 27% lift in revenue during 2015. The company said its pretax profit rose to GBP31.8 million in 2015 from GBP25.2 million in 2014, as revenue climbed to GBP301.8 million from GBP237.9 million. However, Clarkson warned on turbulence in shipping and offshore markets in its outlook for 2016. "The challenges witnessed across the global shipping markets have continued into 2016. The macro-economic environment remains very uncertain and as such we do not anticipate any changes to our markets in the near term," said Chairman James Hughes-Hallett.

Howden Joinery Group, down 1.9%. Jefferies cut its recommendation on the kitchen manufacturer to Hold from Buy
----------
MAIN MARKET AND AIM - WINNERS
----------
APC Technology Group, up 17%. The electronic components supplier said it appointed Art Russell as its chief financial officer, and its Advanced Power Components business saw its best first half performance in terms of bookings since 2011. The company said the Advanced Power Components business saw bookings of GBP7.2 million in the half year to end-March, up 28% compared to the comparative period the previous year. It did not provide the comparative figure. This included bookings of GBP1.8 million in February, which were the highest ever recorded in a single month, it said.

Trading Emissions, up 17%. The environmental and emission assets investor said a further arbitration claim of around EUR5.6 million that had been lodged against the company by a subsidiary of Yunnan Dianneng (Group) Holding Co has been terminated. The arbitration was in relation to claims challenging amendments made to a total of six emissions reductions purchase agreements between Trading Emissions and a project company owned by Dianneng. Additionally, Trading Emissions was awarded HKD289,105 in relation to its legal costs.

Telit Communications, up 16%. The machine-to-machine communication products and services provider said it is confident it will maintain its double digit revenue growth in 2016, underpinned by a positive outlook for the 'internet of things' space, as it reported a rise in pretax profit in 2015. Telit Communications said its pretax profit rose 14% to USD15.9 million in 2015 from USD13.9 million in 2014, as revenue rose 13% to USD333.5 million from USD294.0 million. Within this, Telit saw a 60% rise in revenue from its automotive business to USD39.6 million from USD24.8 million, and a 30% rise in revenue for its Services division to USD26 million from USD20 million.
----------
MAIN MARKET AND AIM - LOSERS
----------
fastjet, down 35%. The Eastern and Southern Africa focused carrier said issued a profit warning for 2016 following "prolonged" challenges in the African aviation industry. The airline said challenging market conditions affecting much of the aviation industry on the continent have been "a lot more prolonged" than it had originally forecast, and therefore, results for 2016 will be "materially below" market expectations. Fastjet also no longer expects to be cashflow positive for the year, but said it has sufficient funds to meet its operational requirements, with over USD20 million of cash available at the end of February.

Hydrodec Group, down 14%. Hydrodec said it has disposed of its UK operations to Andrew Black, a non-executive director and shareholder, for a nominal GBP1. Black also is taking on GBP1.2 million in the third-party debt owed by the operations, while Hydrodec will retain a 10% royalty entitlement. Hydrodec said it undertook a strategic review of its UK operations, which comprise Hydrodec (UK) and Hydrodec Re-Refining (UK), following a "significant deterioration" in the outlook of the businesses due to falling oil prices, making them unprofitable.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.